Tubulointerstitial nephritis in primary Sjögren syndrome: Clinical manifestations and response to treatment

BMC Musculoskeletal Disorders

Volumn 17, Issue 1, 2016, Pages

  Evans, Rhys D R ^a   Laing, Christopher M ^a   Ciurtin, Coziana ^b   Walsh, Stephen B ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Epithelial inflammation; Glomerulonephritis; Immunosuppression; Renal tubular acidosis; Sj gren syndrome; Tubulointerstitial nephritis

Indexed keywords

CORTICOSTEROID; CREATININE; MYCOPHENOLIC ACID; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ACIDOSIS; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE AGED; NEEDLE BIOPSY; SJOEGREN SYNDROME; TREATMENT RESPONSE; TUBULAR DYSFUNCTION; UNITED KINGDOM; URINE ACIDIFICATION; ANALOGS AND DERIVATIVES; CASE REPORT; COMPLICATION; NEPHRITIS, INTERSTITIAL; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NEPHRITIS, INTERSTITIAL; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 84959510993     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-015-0858-x     Document Type: Article

References (30)

1. Sjögren H. Zur Kenntnis Der Keratoconjunctivitis Sicca Ii. Acta Ophthalmol (Copenh). 1935;13(1-39).
2. Moutsopoulos HM. Sjögren's syndrome: Autoimmune epithelitis. Clin Immunol Immunopathol. 1994;72:162-5.
3. Aasarød K, Haga H-J, Berg KJ, Hammerstrøm J, Jørstad S. Renal involvement in primary Sjögren's syndrome. QJM. 2000;93:297-304.
4. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol. 2007;32:265-74.
5. Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjögren's syndrome: Clinical presentation and outcome. Arthritis Rheum. 2013;65:2945-53.
6. Talal N, Zisman E, Schur PH. Renal Tubular Acidosis, Glomerulonephritis and Immunologic Factors in Sjogren's Syndrome. Arthritis Rheum. 1968;11:774-86.
7. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-8.
8. Walsh SB, Shirley DG, Wrong OM, Unwin RJ. Urinary acidification assessed by simultaneous furosemide and fludrocortisone treatment: An alternative to ammonium chloride. Kidney Int. 2007;71:1310-6.
9. Wrong O, Davies HEF. The Excretion of Acid in Renal Disease. QJM. 1959;28:259-313.
10. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum. 2008;58:15-25.
11. Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J Immunol. 1993;150:3615-23.
12. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, et al. Primary Sjögren Syndrome in Spain: Clinical and Immunologic Expression in 1010 Patients. Med (Baltimore). 2008;87:210-9.
13. Ramos-Casals M, Brito-Zerón P, Solans R, Camps M-T, Casanovas A, Sopenã B, et al Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology. 2014;53:321-31.
14. Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, et al. Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant. 2001;16:2328-36.
15. Amarante GBD, Zotin MC, Rocha E, Delgado AG, Jr. ML, Gomes CP. Renal tubular dysfunction in patients with primary Sjögren syndrome. Clin Nephrol. 2014;81:185-91.
16. Pertovaara M, Korpela M, Kouri T, Pasternack A. The occurrence of renal involvement in primary Sjögren's syndrome: A study of 78 patients. Rheumatology. 1999;38:1113-20.
17. Ren H, Wang W-M, Chen X-N, Zhang W, Pan X-X, Wang X-L, et al. Renal involvement and followup of 130 patients with primary Sjögren's syndrome. J Rheumatol. 2008;35:278-84.
18. Eriksson P, Denneberg T, Larsson, L & Lindström F. Biochemical Markers of Renal Disease in Primary Sjögren's Syndrome. (2010). At http://informahealthcare.com/doi/abs/10.3109/00365599509180018.
19. Bogdanović R, Basta-Jovanović G, Putnik J, Stajić N & Paripović A. Renal involvement in primary Sjogren syndrome of childhood: Case report and literature review. (2014). At http://informahealthcare.com/doi/abs/10.3109/s10165-012-0633-x.
20. Takada K, Takiguchi M, Konno A, Inaba M. Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: A model for primary Sjögren's syndrome. Rheumatology. 2004;43:858-62.
21. Rosenberg M, Schendel P, Fa M, Jl P. Characterization of immune cells in kidneys from patients with Sjogren's syndrome. Am J Kidney Dis Off J Natl Kidney Found. 1988;11:20-2.
22. Matsumura R, Kondo Y, Sugiyama T, M S, T K, K T, et al. Immunohistochemical identification of infiltrating mononuclear cells in tubulointerstitial nephritis associated with Sjogren's syndrome. Clin Nephrol. 1988;30:335-40.
23. Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM. Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren's Syndrome Immunopathogenesis. Am J Pathol. 2009;175:1167-77.
24. Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, et al. Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Ann. Rheum. Dis. Annrheumdis-2013-204584 (2014). Doi: 10.1136/annrheumdis-2013-204584.
25. Kapsogeorgou EK, Christodoulou MI, Panagiotakos DB, Paikos S, Tassidou A, Tzioufas AG, et al. Minor Salivary Gland Inflammatory Lesions in Sjögren Syndrome: Do They Evolve? J Rheumatol. 2013;40:1566-71.
26. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X, Tzioufas AG. Topical and systemic medications for the treatment of primary Sjögren's syndrome. Nat Rev Rheumatol. 2012;8:399-411.
27. Preddie DC, Markowitz GS, Radhakrishnan J, Nickolas TL, D'Agati VD, Schwimmer JA, et al. Mycophenolate Mofetil for the Treatment of Interstitial Nephritis. Clin J Am Soc Nephrol. 2006;1:718-22.
28. Morris R, Fudenberg H. Impaired renal acidification in patients with hypergammaglobulinaemia. Med Baltim. 1967;46:57-69.
29. Spruce BA, Baylis PH, Kerr DN, Morley AR. Idiopathic hypergammaglobulinaemia associated with nephrogenic diabetes insipidus and distal renal tubular acidosis. Postgrad Med J. 1984;60:493-4.
30. Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, et al. Renal Involvement in Primary Sjögren's Syndrome: A Clinicopathologic Study. Clin J Am Soc Nephrol. 2009;4:1423-31.